Sen. Hassan Meets With Acting FDA Commissioner, Presses for Answers on FDA's Actions Regarding Opioid Crisis
July 24, 2019
July 24, 2019
WASHINGTON, July 24 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
Senator Maggie Hassan yesterday met with Acting Commissioner of the Food and Drug Administration (FDA) Ned Sharpless calling for a fuller accounting of the FDA's decision-making processes for the approval and labeling of opioid drugs.
The meeting follows a March 2019 letter from Senators Hassan and Ed Markey (D-MA) to former FDA Commissioner Scott Gottlieb outlining a num . . .
Senator Maggie Hassan yesterday met with Acting Commissioner of the Food and Drug Administration (FDA) Ned Sharpless calling for a fuller accounting of the FDA's decision-making processes for the approval and labeling of opioid drugs.
The meeting follows a March 2019 letter from Senators Hassan and Ed Markey (D-MA) to former FDA Commissioner Scott Gottlieb outlining a num . . .